CVE-2026-17583
Thermo Fisher · Applied Biosystems Genetic Analyzers (Data Collection Software)
A vulnerability in Thermo Fisher Applied Biosystems software allows potential unauthorized modification of data files due to a lack of digital signature verification.
Executive summary
An 8.4-severity vulnerability in Thermo Fisher Applied Biosystems genetic analysis software allows for the unauthorized modification of data files, necessitating an urgent software update.
Vulnerability
This vulnerability allows for the modification of instrument data files due to missing integrity checks. It can be triggered by an attacker without requiring specific authentication, posing a risk to the integrity of sensitive research or clinical data.
Business impact
Successful exploitation allows an attacker to alter results generated by the genetic analyzers, which could lead to compromised research data or clinical inaccuracies. The CVSS score of 8.4 reflects the high risk to data integrity, which is critical for medical and scientific environments using these platforms.
Remediation
Immediate Action: Update the affected software to the versions provided in the Thermo Fisher security bulletin, specifically version 4.0.3 for the 3500/3500xL series.
Proactive Monitoring: Implement strict access control for computers running these applications and monitor for unauthorized file modification events on the storage drives.
Compensating Controls: Ensure that instruments are connected to isolated networks and that physical access to the workstations is strictly controlled.
Exploitation status
Public Exploit Available: Yes (public GitHub PoC)
Analyst recommendation
The presence of a public proof-of-concept combined with the sensitivity of the affected systems makes this a priority for remediation. Organizations must apply the vendor-provided updates immediately to ensure data integrity and prevent unauthorized manipulation of genetic analysis results.